XPS™ to be launched in Europe!
The XPS™ has been successfully used in the USA within the framework of the NOVEL study. We are now launching our newly developed appliance for lung perfusion in Europe on the basis of good clinical results and great interest from clinics. This fully integrated off-the-shelf cardiac bypass system is based on innovative technology from leading companies. XPS provides a comprehensive platform for ex vivo lung perfusion (EVLP) evaluation and assessment.
The XPS is planned to receive a CE-mark during the first quarter of 2014 together with the accompanying disposable products.